A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
Receive an email update when we add a new CROHNS DISEASE article.
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Crohn's & Colitis Foundation Review of the Role of Medical Cannabis in the Management of Crohn's and Colitis Published in IBD Journal on November 12, 2018 at 12:12 pm
"The Foundation is dedicated to accelerating research to drive the continuum from new discovery to optimal care," said Michael Osso, President & CEO of the Crohn's & Colitis Foundation. "We know our p... […]
- Worse Crohn’s disease activity causes more sleep disturbances on November 12, 2018 at 6:17 am
Qazi T, et al. Inflamm Bowel Dis. 2018;doi:10.1093/ibd/izy324. Patients with worse Crohn’s disease activity experience more disturbances to their sleep patterns, according to research published in Inf... […]
- Crohn’s: a complex malady on November 10, 2018 at 7:17 pm
Crohn’s disease is one of two major forms of irritable bowel disease (IBD). It is a chronic inflammatory disorder that affects the digestive tract and can be localized anywhere from the mouth to anus. ... […]
- Miami Unites for the Survivors Gala Powered by C.A.R.E. for Crohn’s Foundation on November 9, 2018 at 12:56 pm
C.A.R.E. for Crohn’s Foundation will hold their first annual Survivors Gala to bring awareness to Crohn’s Disease and Ulcerative Colitis. On Sunday, November 11, C.A.R.E. will hold their first annual ... […]
- Europe Crohn's Disease Market and Competitive Landscape Report 2018 - ResearchAndMarkets.com on November 9, 2018 at 9:28 am
DUBLIN--(BUSINESS WIRE)--The "Europe Crohn's Disease Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Europe Crohn's Disease Market and ... […]
- Top gastroenterology stories: Entyvio effective in Crohn’s, expert argues for new name for functional gastrointestinal disorders on November 9, 2018 at 7:22 am
Topics discussed included how Entyvio is effective in ‘real-world’ Crohn’s disease and ulcerative colitis, the world of functional gastrointestinal disorders is changing and artificial intelligence is ... […]
- What Is Inflammatory Bowel Disease? on November 7, 2018 at 10:46 am
More than 3 million people have IBD, according to a recent government survey. The two most common forms of IBD are ulcerative colitis and Crohn’s disease. In Crohn's, inflammation can occur anywhere i... […]
- Medical News Today: Best foods for a Crohn's disease flare-up on November 6, 2018 at 6:00 am
In a person with Crohn's disease, a flare-up can cause diarrhea, abdominal pain, and a loss of appetite. Eating the right foods during a flare-up can help ease symptoms and speed recovery. […]
- US Crohn's Disease Market and Competitive Landscape Report 2018: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares ... on November 5, 2018 at 8:49 am
DUBLIN--(BUSINESS WIRE)--The "US Crohn's Disease Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Crohn's Disease Market and Competitive Landscap... […]
via Bing News